Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1990 2
1991 6
1992 5
1993 4
1994 3
1995 3
1996 4
1997 1
1998 1
2001 2
2002 4
2003 5
2004 6
2005 2
2006 5
2007 3
2008 4
2009 9
2010 7
2011 13
2012 13
2013 15
2014 18
2015 19
2016 21
2017 25
2018 30
2019 41
2020 46
2021 56
2022 73
2023 34

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
Bullous Pemphigoid and Other Pemphigoid Dermatoses.
Pratasava V, Sahni VN, Suresh A, Huang S, Are A, Hsu S, Motaparthi K. Pratasava V, et al. Among authors: suresh a. Medicina (Kaunas). 2021 Oct 4;57(10):1061. doi: 10.3390/medicina57101061. Medicina (Kaunas). 2021. PMID: 34684098 Free PMC article. Review.
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.
Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A. Meehan CJ, et al. Among authors: suresh a. Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Nat Rev Microbiol. 2019. PMID: 31209399 Review.
Advances in Molecular Diagnosis of Tuberculosis.
MacLean E, Kohli M, Weber SF, Suresh A, Schumacher SG, Denkinger CM, Pai M. MacLean E, et al. Among authors: suresh a. J Clin Microbiol. 2020 Sep 22;58(10):e01582-19. doi: 10.1128/JCM.01582-19. Print 2020 Sep 22. J Clin Microbiol. 2020. PMID: 32759357 Free PMC article. Review.
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.
Walker TM, Miotto P, Köser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, Comas I, Posey J, Omar SV, Peto TE, Suresh A, Uplekar S, Laurent S, Colman RE, Nathanson CM, Zignol M, Walker AS; CRyPTIC Consortium; Seq&Treat Consortium; Crook DW, Ismail N, Rodwell TC. Walker TM, et al. Among authors: suresh a. Lancet Microbe. 2022 Apr;3(4):e265-e273. doi: 10.1016/S2666-5247(21)00301-3. Lancet Microbe. 2022. PMID: 35373160 Free PMC article.
Biomarkers for Myocarditis and Inflammatory Cardiomyopathy.
Suresh A, Martens P, Tang WHW. Suresh A, et al. Curr Heart Fail Rep. 2022 Oct;19(5):346-355. doi: 10.1007/s11897-022-00569-8. Epub 2022 Aug 1. Curr Heart Fail Rep. 2022. PMID: 35913661 Free PMC article. Review.
Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples.
Cabibbe AM, Spitaleri A, Battaglia S, Colman RE, Suresh A, Uplekar S, Rodwell TC, Cirillo DM. Cabibbe AM, et al. Among authors: suresh a. J Clin Microbiol. 2020 Sep 22;58(10):e00632-20. doi: 10.1128/JCM.00632-20. Print 2020 Sep 22. J Clin Microbiol. 2020. PMID: 32727827 Free PMC article.
Drug delivery for metabolism targeted cancer immunotherapy.
Khodaei T, Inamdar S, Suresh AP, Acharya AP. Khodaei T, et al. Among authors: suresh ap. Adv Drug Deliv Rev. 2022 May;184:114242. doi: 10.1016/j.addr.2022.114242. Epub 2022 Mar 31. Adv Drug Deliv Rev. 2022. PMID: 35367306 Review.
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.
Price TJ, Peeters M, Kim TW, Li J, Cascinu S, Ruff P, Suresh AS, Thomas A, Tjulandin S, Zhang K, Murugappan S, Sidhu R. Price TJ, et al. Among authors: suresh as. Lancet Oncol. 2014 May;15(6):569-79. doi: 10.1016/S1470-2045(14)70118-4. Epub 2014 Apr 14. Lancet Oncol. 2014. PMID: 24739896 Clinical Trial.
429 results